Physician
Hematology
Dr. Constantin Dasanu, MD
|
|
Give Review
Constantin Dasanu practices Hematology. She went to medical school at New York Medical College. Constantin Dasanu, MD is a published doctor and has 102 publications published. The lastest was: 'Action of some proteic and carbohydrate components of Symphytum officinale upon normal and neoplastic cells.' She accepts all Medicare patients.
Publications
- Synchronous gastric and ampullary adenocarcinomas in a hairy cell leukemia patient treated with pentostatin eight years prior.
- HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?
- Autoimmune disorders in patients with hairy cell leukemia: are they more common than previously thought?
- Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
- Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!
- Subcutaneous panniculitis-like T-cell lymphoma in a patient with history of B-cell lymphoma treated successfully with chemotherapy 15 years prior.
- Association Between HBsAg Positivity and Pancreatic Cancer: a Meta-Analysis.
- Recurrent pseudocellulitis due to gemcitabine: Underrecognized and underreported?
- What are the latest pharmacotherapy options for small bowel adenocarcinoma?
- Updates on immunotherapy in non-small cell lung cancer.
- Desmoid Tumor Mimicking GIST Recurrence.
- Second primary pancreatic adenocarcinoma three years after successfully treated index esophageal cancer.
- A curious case of oxaliplatin-induced neurotoxicity: Recurrent, self-limiting dysarthria.
- Prevalence of autoimmune hematologic and non-hematologic conditions in large granular lymphocytic leukemia: exploratory analysis of a series of consecutive patients.
- Immune alterations and immunotherapy prospects in head and neck cancer.
- Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.
- Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies.
- Immune alterations in malignant melanoma and current immunotherapy concepts.
- Malignant Melanoma in Pigmented Skin: Does the Current Interventional Model Fit a Different Clinical, Histologic, and Molecular Entity?
- Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations.
- Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: Is immunosuppression to blame?
- Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches.
- A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia.
- Rapidly progressive colonic dysplasia/neoplasia in a series of treated lung cancer patients: Is paclitaxel involved?
- Newer developments in the immunotherapy of malignant melanoma.
- Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma.
- An unusual presentation of a carcinoid tumor of the common bile duct.
- Muehrcke's lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia.
- Neuroblastoma with a Solitary Intraventricular Brain Metastasis Visualized on I-123 MIBG Scan.
- Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
- Collision tumors: pancreatic adenocarcinoma and mantle cell lymphoma.
- Hepatoid variant of pancreatic cancer: insights from a case and literature review.
- Smoking-induced monoclonal B-lymphocytosis in two female smokers: what are the odds?
- Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?
- Moderate cytopenias in asymptomatic individuals: is screening for autoimmune connective tissue diseases warranted?
- Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis?
- Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors.
- Action of some proteic and carbohydrate components of Symphytum officinale upon normal and neoplastic cells.
- Acute scurvy during treatment with interleukin-2.
- Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.
- A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
- Gemcitabine: vascular toxicity and prothrombotic potential.
- Acute retinal pigment epithelial detachment secondary to pamidronate administration.
- Emerging therapeutic options for advanced enteropancreatic neuroendocrine tumors.
- Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature.
- Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma.
- Images in clinical medicine. Splenic calcification.
- Refractory DKA as first presentation of acromegaly and a potential role for continuous venovenous hemofiltration in its successful management.
- Chasing the reflected wave back into the heart: a new hypothesis while the jury is still out.
- Rapidly Fatal Acute ATLL Emerging After Methotrexate Therapy for Disseminated Psoriasis.
- Details of left ventricular remodeling and the mechanism of paradoxical ventricular septal motion after coronary artery bypass graft surgery.
- High-grade solitary extramedullary plasmacytoma arising in skeletal muscle of a kidney transplant recipient.
- Autoimmune phenomena in untreated and treated marginal zone lymphoma.
- Isolated thrombocytopenia: should we routinely screen for antiphospholipid antibodies?
- Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.
- Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.
- Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.
- Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice.
- Bilateral perinephric diffuse large B-cell lymphoma and synchronous renal oncocytoma.
- Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia.
- Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma.
- A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancer.
- Kidney cancer therapy: new perspectives and avenues.
- Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma.
- Emerging pharmacotherapeutic strategies for cholangiocarcinoma.
- Newer developments in adult T-cell leukemia/lymphoma therapeutics.
- A curious case of a ''burned-out'' hypereosinophilic syndrome.
- Immune alterations in untreated and treated myelodysplastic syndrome.
- Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
- Lemierre syndrome caused by group C streptococci and associated with red cell aplasia and immune thrombocytopenia.
- Polycystic ovary syndrome: focus on platelets and prothrombotic risk.
- Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.
- On the missing link between inflammation and cancer.
- Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.
- Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis.
- Squamous cell lung cancer presenting with pulmonary lymphangitic carcinomatosis.
- Alpha-thalassemia genetic testing: an important anemia diagnostic tool in patients of African heritage.
- Congenital combined deficiency of coagulation factors VII and II in a young adult.
- Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for Creutzfeldt-Jakob disease.
- Thrombocytopenia in NAFLD: is thrombopoietin involved?
- Refractory metastatic thyroid cancer: is Doxorubicin still a valid treatment option?
- Paraneoplastic psoriasiform dermatitis preceding the diagnosis of chronic myelogenous leukemia.
- Thrombocytopenia, NAFLD, and metabolic syndrome: is there a link?
- Tumor fever, paraneoplastic leukocytosis and necrotic liver metastases: a triad worth remembering.
- Hyperviscosity syndrome in a patient with kappa light chain myeloma with cryoglobulin properties and alpha thalassemia.
- Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity.
- Synchronous tumors: adenosquamous carcinoma of pancreas and GIST of stomach.
- Small cell lung cancer with paraneoplastic lipase production.
- Bortezomib: friend or foe of hemolytic anemia?
- Immunotherapy for melanoma: current status and perspectives.
- Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited.
- Diffuse large B-cell lymphoma with lung involvement in a psoriatic arthritis patient treated with methotrexate.
- Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
- Tumor vaccines in 2010: need for integration.
- Complete heart block secondary to bortezomib use in multiple myeloma.
- Chronic lymphocytic leukemia presenting with cholecystitis-like symptoms and gallbladder wall invasion.
- Lasers, stem cells, and COPD.
- Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.
- Large granular lymphocytic (LGL) leukemia in an adult with Down syndrome (47,XX,+21).
- Inherent and iatrogenic immune defects in hairy cell leukemia: revisited.
- Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents.
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
New York Medical College -
Bronx-Lebanon Hospital Center -
Nicolae Testemitanu State University of Medicine and Pharmacy
Drug Facts
| NPI NUMBER | 1922120708 | |
| NPPES Provider LastName | DASANU | |
| NPPES Provider FirstName | CONSTANTIN | |
| NPPES Provider ZIPCode | 922703221 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 778.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 3.21 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922120708 |
| Last Name Of The Provider | DASANU |
| First Name Of The Provider | CONSTANTIN |
| View All |
Similar Doctors
|
Dr. Murthy V. Andavolu, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Henry T. Tsai, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Koushan Siami Namini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Luke Dreisbach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann J. Eisenbraun, MD
This Doctor is OpenDoctor Recommended.
|